|Bid||16.18 x 1100|
|Ask||17.30 x 900|
|Day's Range||16.65 - 17.21|
|52 Week Range||15.40 - 26.75|
|Beta (5Y Monthly)||1.53|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.10|
Nektar Therapeutics' (Nasdaq: NKTR) senior management is scheduled to participate in a virtual fireside chat at the upcoming Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021 at 2:10 p.m. Eastern Time.
Nektar Therapeutics ( NASDAQ:NKTR ) has not performed well recently and CEO Howard Robin will probably need to up their...
Just because a business does not make any money, does not mean that the stock will go down. For example, although...